Dr. Noon for Health Care Professionals

Identify hidden CVD risk earlier

Instant at the point of care

Non-invasive, fast screening from a retinal scan

Clinically validated AI with high diagnostic accuracy

Built for rollout at scale across clinics and programmes

Supports earlier intervention and targeted referrals

Deliver rapid, specialist-level
cardiovascular risk insight 
at the point of care

From imaging that can be performed in primary care, hospital services, or community optometry referral pathways.

CVD facts

No.1

Cause of death in the UK

7.6M

People living with heart or circulatory disease

£9B

Annual cost to the NHS.

85%

of total deaths are preventable

*British Heart Foundation, Cardiovascular Disease Statistics 2024

Smarter tools for everyday clinical care

Dr. Noon brings AI-powered screening into primary and specialty care, helping providers catch silent risks sooner and act with confidence.

Primary care / routine reviews

Opportunistic risk insight during routine consultations
Supports earlier triage and prioritised follow-up
Next step: prevention plan / monitoring / referral as needed

Chronic disease pathways (Diabetes + Hypertension)

Adds vascular risk context within chronic disease management
Supports earlier escalation and optimisation of risk-factor control
Next step: intensify management + coordinate follow-up / pathway escalation

Cardiology triage support

Adds vascular risk context within chronic disease management
Supports earlier escalation and optimisation of risk-factor control
Next step: intensify management + coordinate follow-up/ pathway escalation

Screening programmes (Community + Wellness)

Helps prioritise referrals under capacity constraints
Focus specialist time on higher-risk patients
Next step: urgent vs routine routing based on risk band + clinical context

Cardiovascular Risk and retinal disease detection

Instant risk assessment in seconds

AI analyses retinal vessel patterns and provides a clear risk assessment: Low, Moderate, or High Risk.

Detects retinal diseases with 96% accuracy

AI-powered precision that matches real ophthalmologists.

Strong predictive performance

Clearer risk stratification than traditional hospital-based methods.

Screens for key retinal conditions

Diabetic Retinopathy, Macular Degeneration, Glaucoma, Cataract

Evidence-backed. Clinically validated

Dr. Noon technology is supported by over 50 peer-reviewed publications across leading medical journals, demonstrating performance in cardiovascular and retinal disease detection.

Seamless integration

Dr. Noon fits effortlessly into existing care workflows and screening programs, making adoption simple across clinical settings, at any scale.

Instant, In-Situ Screening

AI-powered screening from a single retinal scan. Non-invasive, accessible, and performed during routine appointments.

Clinically Actionable Insights

Dr. Noon delivers clear, validated results that support earlier decisions, smarter referrals, and more effective care.

Low-friction rollout.
High-throughput potential.

Designed for effortless deployment with minimal setup and a compact footprint (fundus camera-based), suitable for exam rooms, wellness suites, or pop-up screening spaces.

Supports flexible deployment using existing in-house imaging or community optometry fundus capture, without requiring specialist cardiovascular hardware.

Workflow integration support

Guidance to embed Dr. Noon into existing pathways

Dedicated support team

Setup, troubleshooting, ongoing guidance

Training & education

Live demos, guides, ongoing sessions

Comprehensive resources

FAQs, manuals, best practices

See Dr. Noon in practice

Hear from eye care professionals using Dr. Noon in everyday care and how it fits into routine eye exams.

Trusted recognition from healthcare and innovation awards

Bring earlier risk insight into routine care

Start transforming healthcare today.

Seamless onboarding with training and dedicated support.